01:00 PM
Approx. 50 minutesDAPT Post-Stenting in ACS: Does “One Size Fits All” Apply?
Add to calendar
03:00 PM
Approx. 50 minutesAntithrombotics in ACS: Guidelines, Practices, and Possible Future Options
Add to calendar
10:00 AM
Approx. 50 minutesWhat Do Updated Guidelines Mean for Your Patients With AF?
Add to calendar
11:00 AM
Approx. 50 minutesChanging Paradigm of Stroke Prevention With Novel Antithrombotic Therapies
Add to calendar
09:00 AM
Approx. 50 minutesWhat's New in Stroke Prevention and AF: The Top Ten Studies
Add to calendar
10:00 AM
Approx. 50 minutesAtrial Fibrillation: From Pharmacotherapies to Interventional Approaches
Add to calendar
11:00 AM
Approx. 50 minutesTreating and Older Adult- Bringing It All Together Therapies?
Add to calendar
12:00 PM
Approx. 60 minutesWhy Shouldn’t We Ignore Residual CVD Risk?
Add to calendar
May 22nd, 2012
12:00 PM
Approx. 60 minutesCan We Reduce Residual CV Risk by Optimizing Lipid Profile?
Add to calendar
June 7th, 2012
12:00 PM
Approx. 60 minutesResidual CV Risk: Where Have We Been And Where Are We Going?
Add to calendar
September 13th, 2012
Approx. 50 minutes
Managing the Impending Cardiovascular Disease Crisis; Can we Prevent Heart Disease?
Featuring Clyde Yancy, MD from Northwestern Memorial Hospital and Donald Lloyd-Jones, MD from Northwestern University.
Clyde Yancy, MD
Chief, Division of Cardiology
Donald Lloyd-Jones, MD
Chair, Preventive Medicine, Associate Professor
Approx. 50 minutes
Highlights from European Society of Cardiology: Implications for Practice
Featuring Christopher P. Cannon, MD from Brigham and Women’s Hospital and Harvard Medical School and Clyde Yancy, MD from Northwestern Memorial Hospital.
Christopher P. Cannon, MD
Activity Director and Associate Professor of Medicine
Clyde Yancy, MD
Chief, Division of Cardiology
Approx. 50 minutes
Heart failure – disease management to avoid re-hospitalization
Featuring Christopher P. Cannon, MD from Brigham and Women’s Hospital and Michael M. Givertz, MD from Harvard Medical School.
Christopher P. Cannon, MD
Activity Director and Associate Professor of Medicine
Michael M. Givertz, MD
Associate Professor
Approx. 50 minutes
Antiplatet/Anticoagulant Therapy in Patients with Acute Coronary Syndromes – A look at the New ACC/AHA Guidelines
Featuring Christopher P. Cannon, MD from Brigham and Women’s Hospital and Harvard Medical School and Deepak Bhatt, MD from VA Boston Healthcare System.
Christopher P. Cannon, MD
Activity Director and Associate Professor of Medicine
Deepak Bhatt, MD
Chief of Cardiology
Approx. 50 minutes
Optimal Management of LDL Cholesterol and Triglycerides
Featuring Michael Miller, MD from University of Maryland School of Medicine and Steven Jones, MD, FACC, ABCL from Johns Hopkins University School of Medicine.
Michael Miller, MD
Professor of Medicine
Steven Jones, MD, FACC, ABCL
Director and Assistant Professor of Medicine
Approx. 50 minutes
Percutaneous versus Surgical Management of Aortic Valvular Stenosis
Featuring John Conte, MD from Johns Hopkins University School of Medicine and Mary C. Corretti, MD from Johns Hopkins University School of Medicine.
Approx. 50 minutes
Diabetes – Which drugs should we be using and When Should We refer to a Diabetologist
Featuring Joshua A. Beckman, MD, MS from Brigham and Women’s Hospital and Thomas W. Donner, M.D. from Johns Hopkins University School of Medicine.
Joshua A. Beckman, MD, MS
Director Cardiovascular Fellowship Program
Thomas W. Donner, M.D.
Associate Professor of Medicine
Approx. 50 minutes
Biomarkers to Improve Risk Prediction: Focusing on Patient Outcomes and Improvement of Care
Featuring Paul M. Ridker, MD, MPH from Harvard Medical School and Peter Libby, MD from Brigham and Women's Hospital and Harvard Medical School.
Approx. 50 minutes
2012 CardioCareLive Proposed Lipids Guidelines: Why wait for Godot and the IOM?
Featuring Laurence Sperling, MD from Emory University School of Medicine, Roger Blumenthal, MD from Johns Hopkins University School of Medicine, Seth Martin, MD from The Johns Hopkins Hospital, and Thomas Metkus, MD from Brigham and Women’s Hospital.
Laurence Sperling, MD
Professor of Medicine
Roger Blumenthal, MD
Activity Director and Professor of Medicine
Seth Martin, MD
Cardiology Fellow, Division of Cardiology
Thomas Metkus, MD
Brigham and Women's Hospital
Approx. 50 minutes
When to Refer the Patient with Atrial Fibrillation for an Ablation or Left Atrial Appendage Occlusion
Featuring David Spragg, MD from Johns Hopkins University School of Medicine and Roger Blumenthal, MD from Johns Hopkins University School of Medicine.
David Spragg, MD
Assistant Professor of Medicine
Roger Blumenthal, MD
Activity Director and Professor of Medicine
Approx. 50 minutes
Current and Future Strategies to Raise HDL-Cholesterol and Lower CVD Risk
Featuring Daniel J. Rader, MD from University of Pennsylvania School of Medicine and Roger Blumenthal, MD from Johns Hopkins University School of Medicine.
Daniel J. Rader, MD
Professor of Medicine
Roger Blumenthal, MD
Activity Director and Professor of Medicine
Approx. 50 minutes
Anticogulation Alternatives in the Person With Atrial Fibrillation
Featuring Michael D. Ezekowitz, MBChB, DPhill, FACC, FAHP,FRCP, MA from Jefferson Medical College and Ronald D. Berger, MD from Johns Hopkins University School of Medicine.
Michael D. Ezekowitz, MBChB, DPhill, FACC, FAHP,FRCP, MA
Professor of Medicine
Ronald D. Berger, MD
Associate Professor of Medicine
Approx. 50 minutes
Finding the Disease in Heart Failure - Role of Galectin-3 in Heart Failure Development and Progression
Featuring Pieter Muntendam, MD, Chief Medical Officer at BG Medicine. br/ br/ bSponsored by BG Medicine/b br/ br/ *This session is not eligible for iAMA PRA Category 1 Credits TM/i
Pieter Muntendam, M.D.
Chief Medical Officer
Approx. 60 minutes
Role of Galectin-3 in Therapeutic and Cardiovascular Outcomes – Results from Leading Studies Presented at European Society of Cardiology Annual Meeting
Sponsored by BG Medicine and their partners: Abbott, Alere, bioMerieux and Siemens.
*This session is not eligible for AMA PRA Category 1 Credits™
Pieter Muntendam, M.D.
Chief Medical Officer
Approx. 50 minutes
Industry Session: The Role of Lipoprotein Particle Measurement in Cardiovascular Risk Management and Treatment
bRecorded June 29, 2011/bbr/br Featuring James A. Underberg, M.D. from New York University Medical School. br/brbr/br bSponsored by LipoScience/bbr/br *This session is not eligible for iAMA PRA Category 1 Credits TM/i
James A. Underberg, M.D.
Clinical Assistant Professor